Eye drop reminders and check-ins for glaucoma
Part of Eyes & vision clinical trials.
This study tests whether reminders and extra check-ins help people with glaucoma stay on track with their eye drops and clinic visits. It aims to see if these supports keep eyes healthier by preventing missed drops and appointments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with glaucoma or ocular hypertension by an eye doctor.
- You currently use at least one prescription eye drop to lower pressure in your eyes.
- You have missed at least 20% of your prescribed eye drops, or missed 2 or more glaucoma clinic appointments, or your glaucoma is getting worse despite treatment.
- You are willing to take part in the study and attend follow-up visits for about a year.
- You can communicate in the study language (English).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if personalized reminders sent to your phone can help you remember to use your glaucoma eye drops and better control eye pressure.
This study looks at how well people stick to their glaucoma eye drop routine when using a special bottle called EASYGRIP®. If you use this type of bottle for your glaucoma drops, this study may help doctors understand how to make treatment easier.
This study tests a smart cap for your eye drop bottle that records when you use your drops. It is for people with glaucoma who sometimes miss doses and want to track their adherence with a phone app.
This study looks at tools to help people use their glaucoma eyedrops correctly. You may be eligible if you've been on the same drops for 2 months and are a patient at Boston University Eye Associates.
This study tests an eye drop (G01) for people with primary open-angle glaucoma that is getting worse despite current treatments. It aims to see if G01 can safely slow down or stop the progression of glaucoma.
This study checks whether a device called the Nanodropper helps deliver glaucoma medicine as well as standard use. It is for adults with stable primary open-angle glaucoma (or ocular hypertension) who are on a limited number of eye-pressure medicines.
Hear when a new Glaucoma Medication Adherence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.